Discovery of ERBB3 inhibitors for non-small cell lung cancer (NSCLC) via virtual screening
Keyword(s):
2019 ◽
Vol 21
◽
pp. 101301
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):
Keyword(s):